Healthcare / Medical Care FacilitiesNSE
$660.45
+23.85 (+3.75%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $345.5M · quality 53.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
65/100
B
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$66.3B
P/E
81.7x
↑EV/EBITDA
25.0x
↑ROE
6.9%
↑Gross Margin
40.9%
↓Debt/Equity
0.07
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+34.1%
FCF CAGR
—
FCF margin
11.3%
FCF / Net income
1.47x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $9.99B · net income $768.4M · FCF $1.13B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.99B | $9.99B | $7.56B | $5.40B | $4.15B |
| Net Income | $768.4M | $768.4M | $671.0M | $351.3M | $-117.9M |
| EBITDA | $2.48B | $2.48B | $1.81B | $1.07B | $528.7M |
| EPS | 8.10 | 8.10 | 6.69 | 3.50 | -1.17 |
| Gross Margin | 40.9% | 40.9% | 37.2% | 31.7% | 25.0% |
| Operating Margin | 13.6% | 13.6% | 12.5% | 9.9% | 0.9% |
| Net Margin | 7.7% | 7.7% | 8.9% | 6.5% | -2.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.07 | 0.07 | 0.44 | 0.65 | 0.55 |
| Current Ratio | 2.80 | 2.80 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.13B | $1.13B | $345.5M | $-77.2M | $-624.7M |
| Returns | |||||
| ROE | 6.9% | 6.9% | 11.5% | 8.5% | -3.0% |
| Valuation | |||||
| P/E | 81.74 | 81.74 | — | — | — |
| EV/EBITDA | 25.05 | 25.05 | — | — | — |
| P/B | 5.61 | 5.61 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 32.2% | 32.2% | 40.1% | 30.2% | — |
| EPS Growth | 21.1% | 21.1% | 91.0% | 398.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
93.4%
EPS terminal req.
$58.60
Spread vs growth
-72.3%
5Y implied EPS CAGR
54.3%
EPS terminal req.
$70.91
Spread vs growth
-33.2%
10Y implied EPS CAGR
30.3%
EPS terminal req.
$114.20
Spread vs growth
-9.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+40.1%
Start / end P/E
70.5x → 81.5x
EPS bridge
6.69 → 8.10
Residual
+3.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.